Other Guidelines | Page 33 | European Cystic Fibrosis Society (ECFS)

Health Changes in People with CF the Year After Having a Child

Use of swelling tests in mini-guts to help determine eligibility for treatment with Trikafta for a CF patient with a rare mutation

Cystic fibrosis outcomes with Tricare Insurance

Measuring CFTR function and relating it to health.

Using safe sampling and DNA tests to diagnose lung infections in children with cystic fibrosis

Worldwide Estimates of Cystic Fibrosis Diagnosis and Treatment Access

Patient and program characteristics which influence screening for bone mineral disease in people with Cystic Fibrosis

Measuring how the drug elexacaftor/tezacaftor/ivacaftor affects the muscles of breathing, using dynamic chest radiography

Results from a clinical trial of the natural therapeutic alginate OligoG against Burkholderia lung infection in people with cystic fibrosis.

Bacterial communities relate to gut function and transit in the cystic fibrosis gut

first
previous
…
29
30
31
32
33
34
35
36
37
…
next
last